Keita Kikuchi

Accelerate regulatory submissions and lifecycle variations through automation and effective global-to-local collaboration on core packages. Learn how: https://bit.ly/3UdapLc #RIM #regulatory #submissions #biopharma

34

🔑 Find new HCPs treating patients 🔑 Optimize territory alignments 🔑 Activate the field with timely alerts Learn how #VeevaCompass is making these key responsibilities easier for commercial #pharma sales operations: https://bit.ly/4dUkTqr

18

The APAC region is experiencing significant growth in clinical trials, but sourcing equipment presents unique challenges. In this latest article, We discuss: 🔹 Complex import/export regulations 🔹 Local sourcing limitations 🔹 Country-specific hurdles in China, India, Indonesia, and Vietnam 🔹 Cultural differences in equipment use 🔹 Import licenses and IOR requirements Understanding and addressing these issues is crucial for successful clinical trials in APAC. Read more about overcoming these challenges in the full article. 👉 https://lnkd.in/e3HVc2ci #ClinicalTrials #APAC #MedicalResearch #EquipmentSourcing

15

Discover how Interactive Response Technology (IRT) is transforming clinical trials. Learn more in this article as Kevin Landells from IQVIA IRT at IQVIA highlights how IRT enhances efficiency, reliability, and innovation in trial logistics, reducing costs. https://bit.ly/4fpnM2k

22

Discover APAC's Clinical Trial Potential with ClinActis Explore the untapped potential of clinical trials in the APAC region. APAC presents a wealth of opportunities for innovative clinical research, serving as your path to a thriving clinical development program. 💰 Cost Benefits: APAC offers significant cost savings compared to Western regions, with savings up to 60% in some countries, making it an attractive choice for cost-effective research endeavors. 📜 Strict & Efficient Regulatory Bodies: APAC's regulatory bodies have become more streamlined and efficient, with countries like Singapore and South Korea ranking high in regulatory efficiency, ensuring smooth approval processes. 👩‍⚕️ Patient Access & Diverse Demographics: With over 60% of the world's population residing in APAC, access to a diverse participant pool is unparalleled, providing a rich demographic mix for more representative clinical studies. 💊 Huge Drug Development Market Size: The APAC pharmaceutical market is thriving, projected to reach $1.6 trillion by 2025, offering immense opportunities for drug development and market expansion. 🏥 Good Clinical Infrastructure: APAC boasts top-notch clinical research facilities and infrastructure, with countries like South Korea and Australia leading in healthcare quality. Malaysia and Thailand also stand out, offering a good balance between high-quality healthcare and competitive costs. 📊 Data Acceptance by Major Regulatory Bodies: Clinical data from the APAC region is increasingly being accepted by major regulatory bodies like the USFDA and EMA, showcasing the region's credibility and adherence to global standards. ClinActis' Expertise: Leveraging our unique expertise in the APAC region and extensive experience supporting global trials for USFDA and EMA approval, ClinActis is your preferred partner for navigating the intricacies and unlocking the full potential of clinical trials in this diverse and dynamic market. Contact us to learn more about conducting clinical research in APAC and to understand how ClinActis can deliver your APAC clinical trial objectives.  #ClinActis #APACRegion #ClinicalTrials #Innovation #APACClinicalTrials #APACCRO  www.ClinActis.com

19

Discover APAC's Clinical Trial Potential with ClinActis Explore the untapped potential of clinical trials in the APAC region. APAC presents a wealth of opportunities for innovative clinical research, serving as your path to a thriving clinical development program. 💰 Cost Benefits: APAC offers significant cost savings compared to Western regions, with savings up to 60% in some countries, making it an attractive choice for cost-effective research endeavors. 📜 Strict & Efficient Regulatory Bodies: APAC's regulatory bodies have become more streamlined and efficient, with countries like Singapore and South Korea ranking high in regulatory efficiency, ensuring smooth approval processes. 👩‍⚕️ Patient Access & Diverse Demographics: With over 60% of the world's population residing in APAC, access to a diverse participant pool is unparalleled, providing a rich demographic mix for more representative clinical studies. 💊 Huge Drug Development Market Size: The APAC pharmaceutical market is thriving, projected to reach $1.6 trillion by 2025, offering immense opportunities for drug development and market expansion. 🏥 Good Clinical Infrastructure: APAC boasts top-notch clinical research facilities and infrastructure, with countries like South Korea and Australia leading in healthcare quality. Malaysia and Thailand also stand out, offering a good balance between high-quality healthcare and competitive costs. 📊 Data Acceptance by Major Regulatory Bodies: Clinical data from the APAC region is increasingly being accepted by major regulatory bodies like the USFDA and EMA, showcasing the region's credibility and adherence to global standards. ClinActis' Expertise: Leveraging our unique expertise in the APAC region and extensive experience supporting global trials for USFDA and EMA approval, ClinActis is your preferred partner for navigating the intricacies and unlocking the full potential of clinical trials in this diverse and dynamic market. Contact ClinActis to learn more about conducting clinical research in APAC and to understand how we can deliver your APAC clinical trial objectives. Learn more about ClinActis here: https://lnkd.in/gjdkv3Xx #ClinActis #APACRegion #ClinicalTrials #APACClinicalTrials #APACCRO www.ClinActis.com

17

The goal of modular content is high-quality, personalized information faster and at scale. Here’s how to give stakeholders reasons to become your change champions. 👉 https://bit.ly/4bRjsYo #pharmaceuticals #contentstrategy

8

🚀 PACT Member news alert: Veeva Systems introduces the Vault CRM Service Center for inside sales, contact centers, and hybrid reps in life sciences. Unify your teams and drive true customer-centricity with this powerful tool - read their press release at https://bit.ly/4dNrEKg #LifeSciences #CRM #CustomerEngagement #Innovation #SalesMarketing #Veeva #CustomerCentricity

2

**Supercharge Your Veeva CLM: Unlock Hidden Potential 🚀** Are you ready to take your Veeva CLM presentations to the next level? 📈 Discover how to: ✨ Boost engagement ⚡ Improve efficiency ✅ Enhance compliance Read our latest article to learn how you can implement these strategies: https://lnkd.in/expAu74x #Veeva #Marketing #ContentMarketing #Iguazu #Marketing #Pharmaceutical #VeevaSystems #Pharma #Digital #Healthcare #Marketing #PharmaMarketing #CLM

1

It’s time to prepare for another upcoming Veeva Vault release! The Bright Affect team have you covered. This time, the 24R3 release (coming December 6) will deliver a range of enhancements to streamline processes, improve compliance, and enhance the user experience.  Just some of the key updates include: - Improved notification system and simplified Document Viewer  - Streamlined quality processes with automated workflows  - Regulatory improvements for EAEU submissions and EU dossier management  - Mobile interface upgrades and better offline capabilities Read the full details in our article to see how these updates can benefit your organisation: https://lnkd.in/enkW5sqV #SoftwareUpdate #VeevaVault #Implementation #LifeSciences #Pharma #DocumentManagement #SystemsManagement #Article

3

Maximize ROI on Veeva Technology with Strategic User Adoption Planning. Download our Veeva Commercial Brochure to learn more about how we fill the learning gaps with our strategic user adoption planning and unique engagement model. https://lnkd.in/ggisCXW8 #learninganddevelopment #veeva #lifesciences

9

Veeva Systems (NYSE: VEEV) has introduced the Veeva AI Partner Program, aimed at providing partners with the necessary technology and support to seamlessly integrate Generative AI (GenAI) solutions with Veeva Vault applications. Read the full news - https://lnkd.in/dhtBrEav #generativeai #artificialintelligence #innovation #techedgeai #technology #vaultapplication #API

11

#DIA2024 is in full swing! Stop by booth #1730 to connect with Eric Travieso, Tom Natal, and Tracy Mayne on: → Veeva Products. Learn how you can make the transition from Veeva CRM to Veeva Vault CRM. → Digital CRO. Learn how we can help facilitate the creation and submission of real-world evidence for filing. → DATAstream. Learn how you can streamline pharma commercialization with our best-in-class data integration and analytics factory. ...and much more. See you soon! #lifesciences #biotech #slipstream

76

3件のコメント

A robust operational foundation can allow a #ClinicalTrial organization to dive deeper into the function and impact of its medical affairs team. Veeva Systems is joined by industry experts to share insights on how organizations can improve measures of operational effectiveness: https://bit.ly/3C4LItE

2

【Interview with Jing Zhang, CFO of 3D Medicines: Achieve Profitablity with Market Essential Demand Product Portfolio】 🚀 With the distinction of owning the world’s only subcutaneous PD-L1 injection product, 3D Medicines has maintained a gross profit margin of over 90% for years, laying a strong foundation for commercialization. However, the timeline for reaching breakeven remains a key concern for investors. 📢 Futu I&E proudly had an in-depth conversation with Jing Zhang, CFO of 3D Medicines, discussing financial performance, product R&D, and international strategy. 🔑 We’ve distilled some core insights from this conversation to share with you: 🌟 The way to maintain consistently high gross profit margins 🌟 Perspective on international market expansion 🌟 Process of managing pharmaceutical R&D effectively 👉 Please click the link to read the full article: https://lnkd.in/gyWGeSsF #Futu #Futuie #Pharmaceuticals #Innovation #Commercialization #GlobalStrategy #Biotech

2

Ever wondered about the impact of non-promotional scientific activities on treatment adoption? Curious which of the congresses, publications, guidelines, clinical trials, or social media activity is the biggest driver? Answers to these and more in the new Veeva Pulse Field Trends Report: https://bit.ly/4bWrEpt

22